What The Health

🌬️ Diag-Nose.io, a Melb-based biotech developing AI-driven diagnostics for respiratory diseases, closed a $3.15m seed round https://lnkd.in/gwBRW9Sy Keen for more hot healthtech developments? 🍩🙌@ Subscribe to our What The Health Newsletter - link in the comments 💜 📩

🧪 AdvanCell, a clinical-stage radiopharmaceutical company creating innovative cancer therapeutics, raised an oversubscribed US$112m Series C https://lnkd.in/eWM5RgYr Keen for more hot healthtech developments? 🍩🙌@ Subscribe to our What The Health Newsletter - link in the comments 💜 📩

🎉 New Year, New Job? Keen to make an impact in healthcare with AI and retinal imaging? 👀💡 Optain (Australia) is a SaMD company operating between Australia & the US, transforming care with AI-powered retinal imaging. By leveraging the eye as a gateway to systemic health, they’re enhancing how eye and systemic conditions are detected, managed, and treated—making care more accessible while alleviating pressure on healthcare systems. And they’re on the lookout for two key hires! 1️⃣ QA/RA Specialist – Lead compliance and quality as they scale globally. 2️⃣ SaMD Product Owner – Shape product development and accelerate market growth. Links to both roles in the comments below. Preferably based at Optain’s Melbourne HQ, but open to the right candidate. Curious? Keen to apply? Drop your resume at recruiting@optainhealth.com.

📷 Harrison.ai, makers of AI products to analyse medical scans & tests to improve detection and outcomes, announced their US$112m series C including $32m from the National Reconstruction Fund https://lnkd.in/gV6rYvg9 Keen for more hot healthtech developments? 🍩🙌 Subscribe to our What The Health Newsletter - link in the comments 💜 📩

Aussie Healthtech hitting the ground hard in 2025!🎉🩻 Harrison.ai announced their US$112m series C this morning, to scale their AI products that analyse medical scans & tests to improve detection and outcomes 🧪 AdvanCell, a clinical-stage radiopharmaceutical company making innovative cancer therapeutics raised an oversubscribed US$112M Series C 🌬️ Diag-Nose.io, a Melb-based biotech developing AI-driven diagnostics for respiratory diseases, closed an oversubscribed $3.15m seed round 📑 Medow Health AI, a Syd-based startup developing AI 'co-pilot' systems to automate specialist medical reports, raised $2M 📜 Healthy Mend & Mosaica secure $2.5m to launch Vigilis, an AI-powered governance tool for Health & Human Services 🩺 OVUM, a new women’s healthtech app raised a $1.7m pre-seed round 🥄 Spoony, a social app for neurodivergent, disabled, & chronically ill people, raised $1m following a beta launch with 22k users & a 25% reported reduction in loneliness Growth rounds are notoriously hard - but it’s great to see some quality companies crossing that funding chasm Here’s to more! Want the details? Keen for more hot healthtech developments? 🍩🙌 Subscribe to get tomorrow morning's What The Health Newsletter drop - with all the latest happenings and hottest news in healthtech 💜 📩 Link in ze comments below 👇 #healthtech  #health  #healthcare  #digitalhealth  #medtech  #biotech

New Year New Role? Interested in helping transform healthcare - through AI and Retinal Imaging? Optain (Australia) is a software-as-a-medical device (SaMD) company based between Aus & the US - transforming care with AI-enabled retinal imaging technology. Using the eye as a window to systemic health, they’re aiming to improve the way eye and systemic conditions are screened, managed, and treated—to make care more accessible and easing healthcare system strain. And, they’re hiring for two pivotal roles! 1. QA/RA Specialist – Ensure compliance and quality as expanding globally. 2. SaMD Product Owner – Drive product development and market growth. Links to both positions in the comments below. Ideally both based in Optain’s Australia headquarters in Melbourne, but flexible for the right candidate. Want to know more? Or throw your hat in the ring? Send your resume to recruiting@optainhealth.com

What's the state of play in Aussie healthtech funding? Well, our friends at Cut Through Venture & Folklore just dropped their fun lil (130+ page) report on The 2024 State Of Australian Startup Funding 🗞️ (linked below 💥). And since not everyone has time for a full study session, we’ve put together the Cliff Notes version: https://lnkd.in/g6AEgUzu

Welcome to the team 💜🎉🍩

The Bridge Program has extended its application deadline to 9 February 2025.   If you're a mid-career drug development or biotech professional looking to expand your commercialisation knowledge and networks, now's your chance!   Apply now and join a nationwide biotech network! Link: https://lnkd.in/gCkdvDh

What happened in health tech over the holidays? Catch up in our first newsletter of 2025 💥 Link’s in the comments. Subscribe to keep tabs on what’s trending🍩💜 #whatthehealth #healthtech #healthinnovation #aihealth #healthcare #healthy #digitalhealth #healthfunding #aushealth